Clariane Valuation Multiples

Clariane is valued at $1.3B as of October 2026, a 1.6x revenue multiple. In the last 12 months, Clariane revenue was $6.1B and Clariane EBITDA was $1.2B.

Clariane Overview

About Clariane

Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.


Founded

2003

HQ

France

Employees

70.0K

Website

korian.com

Financials (LTM)

Revenue: $6.1B
EBITDA: $1.2B

EV

$9.4B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Clariane Financials

Clariane reported last 12-month revenue of $6.1B and EBITDA of $1.2B.

In the same LTM period, Clariane generated $1.2B in EBITDA and $33M in net income.

Revenue (LTM)


Clariane P&L

In the most recent fiscal year, Clariane reported revenue of $5.9B and EBITDA of $1.1B.

Clariane is profitable as of last fiscal year, with gross margin of 92%, EBITDA margin of 19%, and net margin of 0%.

See analyst estimates for Clariane
LTMLast FY202320242025202620272028
Revenue$6.1B$5.9B$5.8B$6.1B$5.9B
Gross Profit-$5.5B$5.3B$5.6B$5.5B
Gross Margin-92%92%92%92%
EBITDA$1.2B$1.1B$1.1B$1.1B$1.1B
EBITDA Margin20%19%19%19%19%
EBIT Margin6%5%6%5%5%
Net Profit$33M$2M($122M)($64M)$2M
Net Margin1%0%(2%)(1%)0%
Net Debt-$2.3B---

Financial data powered by Morningstar, Inc.

Clariane Stock Performance

Clariane has current market cap of $1.3B, and enterprise value of $9.4B.

Market Cap Evolution


Clariane's stock price is $3.75.

Clariane share price decreased by 11.9% in the last 30 days, and by 13.0% in the last year.

See more trading valuation data for Clariane
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$9.4B$1.3B1.9%-11.9%-18.5%-13.0%$0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Clariane Valuation Multiples

Clariane trades at 1.6x EV/Revenue multiple, and 7.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Clariane

EV / Revenue (LTM)


Clariane Financial Valuation Multiples

As of October 16, 2026, Clariane has market cap of $1.3B and EV of $9.4B.

Clariane has a P/E ratio of 41.2x.

LTMLast FY202320242025202620272028
EV/Revenue1.6x1.6x1.6x1.5x1.6x
EV/EBITDA7.7x8.2x8.5x8.3x8.2x
EV/EBIT24.7x29.7x25.6x28.3x29.7x
EV/Gross Profit-1.7x1.8x1.7x1.7x
P/E41.2xn/m(11.0x)(20.9x)n/m
EV/FCF16.2x15.6x48.2x26.9x15.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Clariane Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Clariane Margins & Growth Rates

Clariane grew revenue by 2% and EBITDA by 7% in the last fiscal year.

In the most recent fiscal year, Clariane reported gross margin of 92%, EBITDA margin of 19%, and net margin of 0%.

See estimated margins and future growth rates for Clariane

Clariane Margins

Last FY202420252026202720282029
Gross Margin92%92%92%-
EBITDA Margin19%19%19%20%
EBIT Margin5%5%5%6%
Net Margin0%(1%)0%1%
FCF Margin10%6%10%9%

Clariane Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth2%6%(3%)2%
Gross Profit Growth-5%(3%)-
EBITDA Growth7%3%0%7%
EBIT Growth23%(9%)(5%)23%
Net Profit Growth2269%(48%)(103%)2269%
FCF Growth(6%)79%72%(6%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Clariane Operational KPIs

Clariane's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Clariane's Rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Clariane's Rule of X is 24% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Clariane
LTMLast FY202320242025202620272028
Rule of 4023%22%---
Bessemer Rule of X26%24%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.1M---
Opex to Revenue-87%86%86%87%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Clariane Competitors

Clariane competitors include Ambea, Ship Healthcare Holdings, InnovAge, Healthcare Services Group, Omada Health, Sienna Senior Living, Ryman Healthcare, Attendo, Sonida Senior Living and Summerset Group Holdings.

Most Clariane public comparables operate across Long-Term Care.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Ambea$1.6B$285M1.7x1.5x9.5x8.1x
Ship Healthcare Holdings$4.5B$192M0.2x0.2x5.7x5.5x
InnovAge$990M$26M1.2x1.2x46.9x12.1x
Healthcare Services Group$1.8B$86M0.7x0.7x15.4x10.5x
Omada Health$260M($10M)3.5x2.9x(91.7x)42.0x
Sienna Senior Living$707M$112M3.4x3.0x21.3x17.2x
Ryman Healthcare$473M($33M)2.2x2.0x(31.1x)24.3x
Attendo$1.9B$388M1.7x1.6x8.4x7.8x

This data is available for Pro users. Sign up to see all Clariane competitors and their valuation data.

Start Free Trial

Acquisitions by Clariane

Clariane has acquired 9 companies to date.

Last acquisition by Clariane was on January 11th 2023. Clariane acquired Grupo5 for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Clariane

Grupo5
Berkley Care Group
Ita mental health
Omedys
Description
Grupo 5 is a Madrid-headquartered provider of mental health and social emergency services across Spain. It manages 65 centers specializing in psychiatric care, brain injury rehabilitation, and addiction treatment, primarily in the Community of Madrid. The company also operates emergency shelters in Andalusia and the Canary Islands, supporting over 10,000 patients annually since its founding in 1988.
Berkley Care Group is a United Kingdom operator of luxury residential care homes for elderly and dementia patients. Three of its five facilities hold 'Outstanding' ratings from the Care Quality Commission, located in Hertfordshire and Bedfordshire. Founded in 2010, the group provides personalized nursing and therapy services to over 200 residents with en-suite accommodations and on-site physicians.
ITA Salud Mental is a Barcelona-headquartered network of clinics across Spain dedicated to treating eating disorders, behavioral disorders, cognitive therapy conditions, neurodevelopmental disorders, addictions, and general psychiatry. Centers in Barcelona and Madrid deliver multidisciplinary programs combining psychotherapy, nutritional therapy, medical care, and family support. The group maintains ongoing research collaborations with scientific communities and updates protocols through a dedicated knowledge management team. Professionals undergo continuous training to implement evidence-based interventions tailored to individual patient needs.
Omedys is a Paris-based teleconsultation service connecting patients in underserved French regions with general practitioners via app and phone. The platform handles 100,000 annual visits with prescriptions sent to pharmacies within hours. Launched in 2020 amid COVID-19, Omedys partners with CPAM for reimbursements and employs 200 board-certified doctors serving rural departments like Creuse and Lozère.
HQ CountrySpainUnited KingdomSpainFrance
HQ City
Madrid
London
Barcelona
Reims
Deal Date11 Jan 202317 Mar 202117 Mar 202112 Dec 2019
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Clariane acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Clariane

When was Clariane founded?Clariane was founded in 2003.
Where is Clariane headquartered?Clariane is headquartered in France.
How many employees does Clariane have?As of today, Clariane has over 70K employees.
Who is the CEO of Clariane?Clariane's CEO is Sophie Boissard.
Is Clariane publicly listed?Yes, Clariane is a public company listed on Euronext Paris.
What is the stock symbol of Clariane?Clariane trades under CLARI ticker.
When did Clariane go public?Clariane went public in 2006.
Who are competitors of Clariane?Clariane main competitors include Ambea, Ship Healthcare Holdings, InnovAge, Healthcare Services Group, Omada Health, Sienna Senior Living, Ryman Healthcare, Attendo, Sonida Senior Living, Summerset Group Holdings.
What is the current market cap of Clariane?Clariane's current market cap is $1.3B.
What is the current revenue of Clariane?Clariane's last 12 months revenue is $6.1B.
What is the current revenue growth of Clariane?Clariane revenue growth (NTM/LTM) is 2%.
What is the current EV/Revenue multiple of Clariane?Current revenue multiple of Clariane is 1.6x.
What is the current EBITDA of Clariane?Clariane's last 12 months EBITDA is $1.2B.
What is Clariane's EBITDA margin?Clariane's last 12 months EBITDA margin is 20%.
What is the current EV/EBITDA multiple of Clariane?Current EBITDA multiple of Clariane is 7.7x.
What is the current FCF of Clariane?Clariane's last 12 months FCF is $581M.
What is Clariane's FCF margin?Clariane's last 12 months FCF margin is 10%.
What is the current EV/FCF multiple of Clariane?Current FCF multiple of Clariane is 16.2x.
How many companies Clariane has acquired to date?As of October 2026, Clariane has acquired 9 companies.
What was the largest acquisition by Clariane?None of the M&A deals Clariane has completed have disclosed valuations.
In how many companies Clariane has invested to date?Clariane hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Clariane

Lists including Clariane

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial